SME Times is powered by   
Search News
Just in:   • India's industrial production registers 1.2 per cent growth in May  • Govt committed to building safe and smart energy future: Minister  • Sanchez defends Spain's defence budget in response to Trump's threats  • Iran says no agreement made to resume US talks  • India’s engineering goods exports to US rose 4.6 pc in May despite tariff turmoil 
Last updated: 13 Mar, 2023  

Tablet.9.Thmb.jpg Centre mulling taking action against e-pharmacies over data misuse

Tablet.9.jpg
   Top Stories
» India's industrial production registers 1.2 per cent growth in May
» Govt committed to building safe and smart energy future: Minister
» QCOs benefit MSMEs by enhancing product quality, consumer satisfaction: Piyush Goyal
» Stock market opens higher as Trump indicates ‘great’ trade deal with India
» Make GIFT IFSC more competitive to attract foreign investments: FM Sitharaman
IANS | 14 Mar, 2023
The Centre is planning to regulate the e-pharmacy industry over misuse of data, sources said.

According to a source, the Health Ministry is working on a policy to regulate the e-pharmacy industry market in the country, and a Group of Ministers (GoM) are in favour of the closure of e-pharmacies. "They did not propose the idea in the present shape. The government can take action against them," the source said.

"Health Ministry has taken note of malpractices reported in the sector which lead to concerns over data privacy, sales of medicines without prescription, and predatory pricing," the source added.

The action follows after the Drugs Controller General of India (DCGI) last month issued a show-cause notice on online pharmacies asking them why action should not be taken against them for selling and distributing drugs without licence.

The notice was issued to online pharmacies including Tata 1mg, Amazon, and Flipkart, for selling and distributing drugs in contravention of provisions of the Drugs and Cosmetics Act, 1940.

"This office has received various representations from time to time raising concerns regarding sale of drugs through online, internet or other electronic platforms including various mobile applications, in contravention to the provisions of the Drugs and Cosmetics Act, 1940 & Rules there under. Such sale includes drugs specified in Schedule H, HI and X which are only allowed to be sold by retail under a valid prescription of a registered medical practitioner and supplied under the supervision of a registered pharmacist," the DCGI had said in the notice.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
84.35
82.60
UK Pound
106.35
102.90
Euro
92.50
89.35
Japanese Yen 55.05 53.40
As on 12 Oct, 2024
  Daily Poll
Do you think Indian businesses will be negatively affected by Trump's America First Policy?
 Yes
 No
 Can't Say
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter